Results 41 to 50 of about 509,312 (356)

3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model [PDF]

open access: yes, 2015
Background & Aims Liver biopsy, the gold standard for assessing liver fibrosis, suffers from limitations due to sampling error and invasiveness. There is therefore a critical need for methods to non-invasively quantify fibrosis throughout the entire ...
Caravan, Peter   +11 more
core   +1 more source

TNFα in Liver Fibrosis [PDF]

open access: yesCurrent Pathobiology Reports, 2015
Hepatocyte death, inflammation, and liver fibrosis are the hallmarks of chronic liver disease. Tumor necrosis factor-α (TNFα) is an inflammatory cytokine involved in liver inflammation and sustained liver inflammation leads to liver fibrosis. TNFα exerts inflammation, proliferation, and apoptosis.
Yang, Yoon Mee, Seki, Ekihiro
openaire   +4 more sources

Exosomes in liver fibrosis: The role of modulating hepatic stellate cells and immune cells, and prospects for clinical applications

open access: yesFrontiers in Immunology, 2023
Liver fibrosis is a global health problem caused by chronic liver injury resulting from various factors. Hepatic stellate cells (HSCs) have been found to play a major role in liver fibrosis, and pathological stimuli lead to their transdifferentiation ...
Yufei Liu   +6 more
doaj   +1 more source

Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: An open-label, non-randomised controlled study [PDF]

open access: yes, 2018
OBJECTIVE: One year of comprehensive continuous care intervention (CCI) through nutritional ketosis improves glycosylated haemoglobin(HbA1c), body weight and liver enzymes among patients with type 2 diabetes (T2D).
Adams, Rebecca N   +10 more
core   +2 more sources

Inflammasomes in Liver Fibrosis [PDF]

open access: yesSeminars in Liver Disease, 2017
AbstractCell death and inflammation are two central elements in the development of liver fibrosis. Inflammasomes are intracellular multiprotein complexes expressed in both hepatocytes and nonparenchymal cells in the liver that are key regulators of inflammation and cell fate.
Alegre F, Pelegrin P, Feldstein AE
openaire   +4 more sources

NOX in liver fibrosis [PDF]

open access: yesArchives of Biochemistry and Biophysics, 2007
NADPH oxidase is a multi-protein complex producing reactive oxygen species (ROS) both in phagocytic cells, being essential in host defense, and in non-phagocytic cells, regulating intracellular signalling. In the liver, NADPH oxidase plays a central role in fibrogenesis.
Samuele, De Minicis, David A, Brenner
openaire   +2 more sources

Ultrasound shear wave elastography for liver disease. A critical appraisal of the many actors on the stage [PDF]

open access: yes, 2016
In the last 12\u200a-\u200a18 months nearly all ultrasound manufacturers have arrived to implement ultrasound shear wave elastography modality in their equipment for the assessment of chronic liver disease; the few remaining players are expected to ...
Cantisani, Vito   +4 more
core   +1 more source

The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
Liver fibrosis involves the proliferation and deposition of extracellular matrix on liver tissues owing to various etiologies (including viral, alcohol, immune, and metabolic factors), ultimately leading to structural and functional abnormalities in the ...
Yu-Lin Zhang   +14 more
doaj   +1 more source

The ability of Hepascore to predict liver fibrosis in chronic liver disease: A meta-analysis [PDF]

open access: yes, 2016
Background & Aims: Hepascore is a serum model that was developed to assess the severity of liver fibrosis. It has been well validated in common causes of chronic liver disease.
Adams, Leon A.   +4 more
core   +2 more sources

Noninvasive Methods, including Transient Elastography, for the Detection of Liver Disease in Adults with Cystic Fibrosis

open access: yesCanadian Journal of Gastroenterology and Hepatology, 2015
BACKGROUND: Liver disease is the third leading cause of mortality in patients with cystic fibrosis (CF). However, detection of CF-associated liver disease (CFLD) is challenging.
Matthew D Sadler   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy